Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh · Delayed Price · Currency is BDT 153.20
+5.20 (3.51%)
At close: Sep 3, 2026
DSE:BXPHARMA Revenue
Beximco Pharmaceuticals PLC. had revenue of 13.63B BDT in the quarter ending March 31, 2026, with 8.08% growth. This brings the company's revenue in the last twelve months to 53.93B, up 12.43% year-over-year. In the fiscal year ending June 30, 2025, Beximco Pharmaceuticals PLC. had annual revenue of 49.12B with 10.65% growth.
Revenue (ttm)
53.93B
Revenue Growth
+12.43%
P/S Ratio
1.27
Revenue / Employee
44.09M
Employees
1,223
Market Cap
68.34B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 49.12B | 4.73B | 10.65% |
| Jun 30, 2024 | 44.39B | 5.12B | 13.05% |
| Jun 30, 2023 | 39.27B | 4.60B | 13.26% |
| Jun 30, 2022 | 34.67B | 5.18B | 17.55% |
| Jun 30, 2021 | 29.49B | 3.88B | 15.16% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dutch-Bangla Bank PLC. | 50.88B |
| Pubali Bank PLC. | 47.67B |
| City Bank PLC. | 47.56B |
| Renata | 44.93B |
| United Power Generation & Distribution Company | 32.51B |
| Berger Paints Bangladesh | 30.32B |
| LafargeHolcim Bangladesh PLC. | 29.77B |
| Eastern Bank PLC. | 29.66B |
Beximco Pharmaceuticals PLC. News
- 2 years ago - Small Cap Stocks: Indus Gas, VAST Resources, Beximco - The Armchair Trader